Silence Therapeutics (SLN) FCF Margin (2024 - 2026)
Silence Therapeutics (SLN) recorded FCF Margin of -3697.39% in the quarter ended Mar 31, 2026, up 4973.73 percentage points from -8671.13% a year earlier and up 47184.96 percentage points from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) FCF Margin (2024 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Silence Therapeutics reported FCF Margin of -11154.74%, down 10997.89 percentage points from the prior year.
- Annual FCF Margin has a five-year change of -10948.74 percentage points (years ended Dec 2020 to Dec 2025).
- Across earlier years, FCF Margin came in at -156.85% in the year ended Dec 31, 2024 (-2.13 pp), -154.72% in the year ended Dec 31, 2023 (+105.87 pp), -260.59% in the year ended Dec 31, 2022 (-304.85 pp) and 44.26% in the year ended Dec 31, 2021 (+250.27 pp).
- The figure for the quarter ended Mar 31, 2026 is the highest quarterly FCF Margin since the quarter ended Dec 31, 2024.
- On a year-over-year basis, FCF Margin rose in 1 of the last five quarters, with an average year-over-year change of -13724.06 percentage points.
- Per Business Quant, the preceding three quarters came in at -50882.35% (quarter ended Dec 31, 2025), -6861.64% (quarter ended Sep 30, 2025) and -9746.43% (quarter ended Jun 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Silence Therapeutics | 529.16 Mn | 457.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -3,697.39% |
| Dec 31, 2025 | -50,882.35% |
| Sep 30, 2025 | -6,861.64% |
| Jun 30, 2025 | -9,746.43% |
| Mar 31, 2025 | -8,671.13% |
| Dec 31, 2024 | -108.84% |
| Sep 30, 2024 | -1,713.68% |
| Jun 30, 2024 | -686.75% |
| Mar 31, 2024 | -58.24% |
API Access
Silence Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();